The Filing Desk

Beta Bionics vs Delcath Systems

Beta Bionics BBNX · Delcath Systems DCTH · Health Care Equipment

Beta Bionics reported revenue of $100 million in fiscal 2025, 1.2 times Delcath Systems' $85 million in fiscal 2025. Beta Bionics' revenue grew 53.9% in its latest year, and Delcath Systems' grew 129.1%. Beta Bionics had an operating margin of -71.5%, against 0.8% at Delcath Systems. Free cash flow was −$56 million at Beta Bionics and $21 million at Delcath Systems.

Side by side

Beta BionicsDelcath Systems
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$100M$85M
Revenue growth53.9%129.1%
Revenue growth a year, last 5 years——
Gross margin55.4%86.2%
Operating margin−71.5%0.8%
Net margin−73.0%3.2%
Free cash flow−$56M$21M
Free cash flow margin−56.1%24.6%
Return on capital—2.8%
Net debt to EBITDA—−101.4x
Dividends and buybacks$0M$6M
Change in diluted share count536.7%40.0%
Last close$16.42$20.55
P/E at the last close—128.4×
Insider trades, last 12 months——
Piotroski F-score—6 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Beta BionicsDelcath Systems
Operating margin
Percent of revenue
Beta BionicsDelcath Systems
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Beta BionicsDelcath Systems

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Beta Bionics and Delcath Systems pages.